Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 05 2017 - 8:05AM
Novavax, Inc. (Nasdaq:NVAX) today announced that management will
present at the 35th Annual J.P. Morgan Healthcare Conference.
Presentation details are as follows:
Date: Thursday, January 12, 2017Time: 9:30 am
U.S. Pacific TimeLocation: California East room, Westin St. Francis
Hotel, San FranciscoLive webcast: novavax.com, “Investors”/
“Events”
The webcast and replay of the presentation will
also be accessible under the “Investors/Events” section of the
website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M™ adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the Company’s website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024